Opthea Appoints Sujal Shah to the Board of Directors : vimarsana.com

Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee Chair...

Related Keywords

Australia , Melbourne , Victoria , Dan Spiegelman , Sujal Shah , Daniel Spiegelman , Jeremy Levin , Silvana Guerci Lena , Fred Guerard , Genentech United States Inc , Carnegie Mellon University Tepper School Of Business , Company Board Of Directors The , Northwestern University , Citigroup Inc , Linkedin , Opthea Limited , Credit Suisse , Roche Group , Gilead Sciences , Risk Committee , Lifesci Advisors , Investment In Biotechnology Companies , Exchange Commission , Risk Committee Chairman , Executive Director , Non Executive Director , Chief Executive Officer , Cymabay Therapeutics , Opthea Board , Chief Financial Officer , Tvardi Therapeutics , Carnegie Mellon University Tepper School , Biomedical Engineering , Fast Track Designation , Genentech United States , Private Securities Litigation Reform Act , Annual Report , Year Report , Sci Advisors ,